Andrew M. Courtwright

Andrew M. Courtwright is a Clinical Associate Professor in the Department of Internal Medicine at the University of Utah, with clinical affiliations at the Huntsman Cancer Institute and University of Utah Hospital. His work bridges Lung Transplantation, Critical Care Medicine, and Medical Ethics, focusing on immunological challenges, ethical decision-making, and post-transplant outcomes.

• Education: MD from University of North Carolina Chapel Hill, PhD in Philosophy (Normative Ethics, Biomedical Ethics), MA in Philosophy, BA in Biology and Philosophy from Rice University.
• Clinical Expertise: Board-certified in Internal Medicine, Critical Care, and Pulmonary Disease.

His research explores:

• Lung Transplantation: HLA antibody sensitization, donor-recipient matching, infectious complications, and retransplantation.
• Ethics: Conflicts over life-sustaining treatment, medical futility, and equity in organ allocation.
• Clinical Epidemiology: Telomere biology in lung disease, post-transplant survival trends, and health disparities.

Recent articles highlight his dual focus on immunological risks in transplantation and ethical frameworks for critical care. He has contributed extensively to journals like Am J Transplant, HEC Forum, and Clin Transplant, with a 2024 study on ECMO bridging strategies. Collaborations with institutions such as Harvard and Massachusetts General Hospital underscore his interdisciplinary approach.